CE

EQS-News: SFC Energy AG, TEST-FUCHS GmbH and Auto AG Group start serial production of the H2Genset after successful market test phase

Retrieved on: 
Wednesday, April 10, 2024
Karl Ritter, Certification, CE, Noise, Environment, Partnership, Research, Carbon, Hydrogen, Telecommunications, Renewable energy

A unique selling point is the possibility of refuelling the integrated tanks of the H2Genset at hydrogen filling stations.

Key Points: 
  • A unique selling point is the possibility of refuelling the integrated tanks of the H2Genset at hydrogen filling stations.
  • Only in April 2022, SFC Energy, TEST-FUCHS and Auto AG Group signed a cooperation partnership for the joint development of the H2Genset.
  • The trailer-mounted power generator produces reliable and emission-free energy and is designed for 10 kW nominal and 28 kW peak output.
  • Marc Ziegler, CEO of Auto AG Group: “The H2Genset is the result of three innovative partners bundling their know-how.

Xlife Sciences AG Announces Collaboration Agreement Between its Portfolio Company FUSE-AI GmbH and T-Systems Switzerland

Retrieved on: 
Wednesday, April 10, 2024
Cloud, European Economic Area, MRI, CE, Partnership, Research, Science, Radiology, AI, Software, T-Systems, EEA, MDR, PACS, BSI Group, Health, BSI, Medical device

Xlife Sciences is pleased to announce a collaboration between its portfolio company, FUSE-AI, and T-Systems Switzerland.

Key Points: 
  • Xlife Sciences is pleased to announce a collaboration between its portfolio company, FUSE-AI, and T-Systems Switzerland.
  • T-Systems Switzerland, as a subsidiary of T-Systems International GmbH, is considered a system-relevant IT and digitalization partner in the healthcare sector in Switzerland.
  • Through this cooperation, T-Systems Switzerland distributes the AI-based solution for prostate analysis from FUSE-AI centrally in Switzerland, thereby enabling the commercialization of «Prostate.Carcinoma.ai» for radiological clinics and practices.
  • Xlife Sciences sees this partnership as a significant contribution to continuing its mission to bridge the gap between innovations and the needs of the healthcare market.

Airdoc Technology Unveils 2023 Financial Highlights, Revenue by 79%, Serving 6.83 Million cases

Retrieved on: 
Wednesday, April 10, 2024
Tsinghua University, OCTA, Alzheimer's disease, Finance, CE, Patient, Artificial intelligence, Adolescence, World's fair, Medical device regulation, Dementia, CNV, Certification, Hyperthyroidism, HK, Partnership, Policy, MICCAI, Safety, Lighting, Optical coherence tomography angiography, Intelligence, Choroidal neovascularization, Journal, Hospital, Research, Near-sightedness, Amblyopia, AI, Insurance, Strabismus, AMD, Gold medal, Diagnosis, Peking University, Conference, Growth, Biomarker, Plaque, News, Bleeding, Google Images, Rehabilitation, Medical device

Airdoc Technology Unveils 2023 Financial Highlights, Revenue by 79%, Serving 6.83 Million cases

Key Points: 
  • Airdoc Technology Unveils 2023 Financial Highlights, Revenue by 79%, Serving 6.83 Million cases
    On March 27, medical artificial intelligence company Airdoc Technology (2251.
  • In 2023, through our SaMDs and health risk assessment solutions, we serviced a total of 6.83 million cases and identified 31,459 significant positive cases.
  • In 2023, Airdoc Medical broadened its reach to include hospitals, grassroots medical institutions such as community clinics, and health examination centers.
  • In June 2023, Airdoc, in collaboration with Tsinghua University's Chang Gung Hospital, developed and validated a new deep learning-based neovascular segmentation model.

EQS-News: Celanese and Secarna Pharmaceuticals Enter into RNA Research Collaboration for Long-Acting Antisense Therapies

Retrieved on: 
Wednesday, April 10, 2024
CE, Asos, Drug discovery, Central nervous system, Patient, Ophthalmology, RNA, Research, CBO, Protein, Drug development, Medical device

EQS-News: Secarna Pharmaceuticals GmbH & Co. KG

Key Points: 
  • EQS-News: Secarna Pharmaceuticals GmbH & Co. KG
    The issuer is solely responsible for the content of this announcement.
  • Dallas, TX, USA and Martinsried, Germany, March 20, 2024 – Celanese Corporation (NYSE: CE), a global specialty materials and chemical company, and Secarna Pharmaceuticals GmbH & Co. KG, a leading independent European antisense drug discovery and development company, today announced a research collaboration for the development of long-acting implants that deliver antisense oligonucleotides (ASOs).
  • “Collaborating with Secarna allows us to develop an innovative implant that has the potential to significantly change the way disease-modifying ASO therapies are administered,” said Cyonna Holmes, Global Business Strategy Leader for Ophthalmology and RNA at Celanese.
  • “We are looking forward to partnering with Celanese to combine our industry-leading ASO platform with their VitalDose® drug delivery technology,” said Konstantin Petropoulos, CBO of Secarna Pharmaceuticals.

Toyard Introduces Anime Plush Collection For Entrepreneurs Looking To Leverage Anime Mascots

Retrieved on: 
Monday, March 18, 2024
Organization, CE, EN71, Research, ASTM, Life, Collection, Animal, Toy

The custom plushes feature trendy characters from across the anime universe

Key Points: 
  • Shenzhen City, China--(Newsfile Corp. - March 18, 2024) - Toyard, a custom anime plush manufacturer based out of Shenzen, has announced the launch of a new custom anime plush collection for businesses across the planet.
  • The latest collection features Among Us Plush, Animal Crossing Plush, Angry Birds Plush, Battle Cat Plush, Baron Bunny Plush, Bendy Plush, Big Kirby Plush and Club Penguin Plush.
  • Our Custom Anime Plush Collection provides entrepreneurs with a powerful tool to differentiate their brands.
  • Businesses interested in the custom anime plush collection or seeking a sample can visit the Toyard website today.

Grifols Procleix ArboPlex Assay® Receives CE Mark, the First and Only 4-in-1 NAT for Arbovirus Screening

Retrieved on: 
Thursday, April 4, 2024
Certification, Plasma, CE, GRFS, Risk, Arbovirus, Climate, RNA, GRF, Fever Dream, IVDR, Chikungunya, Death, Dengue virus, MCE, Blood bank, NAT, Vertically transmitted infection, Medical device

These are the four most significant arboviruses of concern, all spread through mosquito vectors.

Key Points: 
  • These are the four most significant arboviruses of concern, all spread through mosquito vectors.
  • With the dengue virus alone, there were more than 5 million cases and 5,000 deaths reported globally in 2023.1
    Further strengthening the Grifols Procleix portfolio for blood donor screening, the Procleix ArboPlex Assay uses plasma or serum samples to detect arboviral RNA.
  • Blood banks and collection centers could decide that deferrals are unnecessary if donors were tested and found negative using the Procleix ArboPlex Assay.
  • “With its 4-in-1 arbovirus test feature, the Grifols Procleix ArboPlex Assay has the ability to speed up and overall improve donor screening laboratory efficiency,” said Antonio Martínez, president of Grifols Diagnostic Business Unit.

Nilam Resources, Inc. Appoints Pranjali More as Interim Chief Executive Officer, Updates the Market Regarding the Caveat Emptor Status and Mindwave Acquisition

Retrieved on: 
Thursday, March 28, 2024
Caveat, Letter, CE, IBN, Information technology, Bank statement, OTC, BTC, Interim, Security (finance)

Prior to being appointed as Interim CEO, Ms. More, served as the Company’s Chief Operating Officer.

Key Points: 
  • Prior to being appointed as Interim CEO, Ms. More, served as the Company’s Chief Operating Officer.
  • As interim CEO she will be able to add continuity to operations while Nilam Resources, Inc. looks to permanently fill the Chief Executive role.
  • Xyberdata is a Mauritius corporation and financial statements from places other than Mauritius do not represent its actual financial status.
  • Nilam Resources is diligently working with OTC Markets to resolve the Caveat Emptor designation as quickly as possible.

RegEd Announces Significant Enhancements to its Market-Leading Xchange Producer Management Solution and Strategic Rebranding to Xchange iX

Retrieved on: 
Tuesday, March 26, 2024
Xchange, Automation, CE, Salesforce, Rheged, Insurance, API, Ix, Medical device

Raleigh, NC, March 26, 2024 (GLOBE NEWSWIRE) -- RegEd, a leader in producer management and licensing automation, today proudly unveiled its strategic rebranding of its flagship Xchange solution to Xchange iX, ushering in a transformative era for intelligent and autonomous producer management solutions which span onboarding, licensing and appointment, and credentialing within the financial services sector.

Key Points: 
  • Raleigh, NC, March 26, 2024 (GLOBE NEWSWIRE) -- RegEd, a leader in producer management and licensing automation, today proudly unveiled its strategic rebranding of its flagship Xchange solution to Xchange iX, ushering in a transformative era for intelligent and autonomous producer management solutions which span onboarding, licensing and appointment, and credentialing within the financial services sector.
  • Frictionless User Experience and Management by Exception: Xchange iX harnesses advanced automation to minimize manual tasks, offering seamless, end-to-end producer management and licensing.
  • Future-Ready Design: Xchange iX is built to adapt and scale, ready to meet the forthcoming waves of industry changes.
  • Continuous updates and expansions in business process automation and API integrations ensure that Xchange iX remains at the forefront of technological advancement.

WiSA Technologies Announces Nasdaq Acceptance of Compliance Plan

Retrieved on: 
Tuesday, April 9, 2024
Mobile, Wireless, Entertainment, Film & Motion Pictures, Consumer Electronics, Technology, General Entertainment, Other Entertainment, TV and Radio, Music, Audio, Video, Other Technology, Electronic Games, Platin, Bang & Olufsen, Sport, CE, Panel, Name, WiSA, Electronics, TCL, Wireless speaker, Ecosystem, Harman International, Cryptocurrency

WiSA Technologies, Inc. (Nasdaq: WISA (the “Company”)), a leading innovator in wireless audio technology for intelligent devices and next-generation home entertainment systems, announced today that it received a decision from the Nasdaq Hearings Panel (the “Panel”) granting its request for continued listing on The Nasdaq Capital Market, subject to the Company demonstrating compliance with certain Nasdaq Listing Rules (the “Nasdaq Rules”), including the achievement of various interim milestones.

Key Points: 
  • WiSA Technologies, Inc. (Nasdaq: WISA (the “Company”)), a leading innovator in wireless audio technology for intelligent devices and next-generation home entertainment systems, announced today that it received a decision from the Nasdaq Hearings Panel (the “Panel”) granting its request for continued listing on The Nasdaq Capital Market, subject to the Company demonstrating compliance with certain Nasdaq Listing Rules (the “Nasdaq Rules”), including the achievement of various interim milestones.
  • WiSA Technologies, Inc. (Nasdaq: WISA) is a leading provider of immersive, wireless sound technology for intelligent devices and next-generation home entertainment systems.
  • WiSA Technologies, Inc. and the WiSA Technologies, Inc. logo are trademarks of WiSA Technologies, Inc.
  • The WiSA logo, WiSA®, WiSA Ready™, and WiSA Certified™ are trademarks and certification marks of WiSA, LLC.

Celanese Completes Series of Strategic Actions Across its Global Acetyl Chain

Retrieved on: 
Tuesday, April 9, 2024
Sustainability, Chemicals, Plastics, Environment, Manufacturing, Carbon, Methanol, Adhesive, Building material, VAE, Acetyl group, CE, Acetic acid, Corporation, Food packaging, Carbon monoxide, CCU, Plant, ISCC, AC, Chemical substance, CO2, RDP

Celanese Corporation (NYSE: CE), a global specialty materials and chemical company, today announced several strategic milestones at its Clear Lake, Texas, and Nanjing, China, plants to enhance the competitive cost position, sustainable footprint and operational flexibility of the Acetyl Chain (AC) business and allow it to meet future demand growth.

Key Points: 
  • Celanese Corporation (NYSE: CE), a global specialty materials and chemical company, today announced several strategic milestones at its Clear Lake, Texas, and Nanjing, China, plants to enhance the competitive cost position, sustainable footprint and operational flexibility of the Acetyl Chain (AC) business and allow it to meet future demand growth.
  • The low-carbon methanol can provide customers with low-carbon ECO-CC AC and Engineered Materials downstream products for a wide range of consumer applications.
  • The startup of a new vinyl acetate ethylene (VAE) unit in Nanjing and completion of global, low-capital downstream redispersible polymer powders (RDP) debottlenecking projects.
  • The Celanese subsidiary, Celanese (Nanjing) Chemical Co. Ltd., has extended its CO Phase II contract with Nanjing Chengzhi Clean Energy Co., Ltd. for the supply of carbon monoxide to its facility in Nanjing.